DSH-004

DSH-004 is a preclinical biomaterial candidate developed by Cellontech, specifically designed for soft tissue reconstruction and the repair of soft tissue defects. As part of Cellontech's regenerative medicine pipeline, DSH-004 likely leverages the company's proprietary atelocollagen technology to provide a biocompatible scaffold for tissue engineering. The product is intended to fill voids or defects in soft tissues, providing immediate structural support while facilitating the infiltration of host cells and the subsequent regeneration of natural tissue. This biomaterial is being developed for use in various reconstructive and aesthetic surgical procedures where tissue volume restoration is required.